Evidence map›Paper›PMID 35293990›Full record

ArticleBrain : a journal of neurology2022

Biallelic CACNA2D1 loss-of-function variants cause early-onset developmental epileptic encephalopathy.

Shehrazade Dahimene, Leonie von Elsner, Tess Holling, Lauren S Mattas, Jess Pickard, Davor Lessel, Kjara S Pilch, Ivan Kadurin, Wendy S Pratt, Igor B Zhulin and 5 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Autism-Linked Mutations in αPharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models.Molecular therapy. Methods & clinical development · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Shehrazade DahimeneDepartment of Neuroscience Physiology and Pharmacology, University College London (UCL), London WC1E 6BT, UK.
Leonie von ElsnerInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Tess HollingInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Lauren S MattasNeurology and Neurological Sciences, Pediatrics, Division of Medical Genetics, Stanford University and Lucile Packard Children's Hospital, Palo Alto, CA 94304, USA.
Jess PickardDepartment of Neuroscience Physiology and Pharmacology, University College London (UCL), London WC1E 6BT, UK.
Davor LesselInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0003-4496-244X
Kjara S PilchDepartment of Neuroscience Physiology and Pharmacology, University College London (UCL), London WC1E 6BT, UK.
Ivan KadurinDepartment of Neuroscience Physiology and Pharmacology, University College London (UCL), London WC1E 6BT, UK.
Wendy S PrattDepartment of Neuroscience Physiology and Pharmacology, University College London (UCL), London WC1E 6BT, UK.
Igor B ZhulinDepartment of Microbiology and Translational Data Analytics Institute, The Ohio State University, Columbus, OH, 43210, USA.ORCID 0000-0002-6708-5323
Hongzheng DaiDepartment of Molecular and Human Genetics, Baylor College of Medicine/NGS-Molecular, Baylor Genetics, Houston, TX, USA.
Maja HempelInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Maura R Z RuzhnikovNeurology and Neurological Sciences, Pediatrics, Division of Medical Genetics, Stanford University and Lucile Packard Children's Hospital, Palo Alto, CA 94304, USA.
Kerstin KutscheInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0001-8494-8963
Annette C DolphinDepartment of Neuroscience Physiology and Pharmacology, University College London (UCL), London WC1E 6BT, UK.ORCID 0000-0003-4626-4856
University College London · GBUniversität Hamburg · DELucile Packard Children's Hospital · USBaylor College of Medicine · USThe Ohio State University · US

Funding

Computational Genomics of Signal TransductionR35GM131760 · NIGMS · OHIO STATE UNIVERSITY · PI Igor B. Jouline · 2019 to 2026
$3.2M
Medical Research Council MR/W001373/1NIGMS NIH HHS R35 GM131760Wellcome Trust 206279/Z/17/Z
6 · The paper itself

Abstract

Voltage-gated calcium (CaV) channels form three subfamilies (CaV1-3). The CaV1 and CaV2 channels are heteromeric, consisting of an α1 pore-forming subunit, associated with auxiliary CaVβ and α2δ subunits. The α2δ subunits are encoded in mammals by four genes, CACNA2D1-4. They play important roles in trafficking and function of the CaV channel complexes. Here we report biallelic variants in CACNA2D1, encoding the α2δ-1 protein, in two unrelated individuals showing a developmental and epileptic encephalopathy. Patient 1 has a homozygous frameshift variant c.818_821dup/p.(Ser275Asnfs*13) resulting in nonsense-mediated mRNA decay of the CACNA2D1 transcripts, and absence of α2δ-1 protein detected in patient-derived fibroblasts. Patient 2 is compound heterozygous for an early frameshift variant c.13_23dup/p.(Leu9Alafs*5), highly probably representing a null allele and a missense variant c.626G>A/p.(Gly209Asp). Our functional studies show that this amino-acid change severely impairs the function of α2δ-1 as a calcium channel subunit, with strongly reduced trafficking of α2δ-1G209D to the cell surface and a complete inability of α2δ-1G209D to increase the trafficking and function of CaV2 channels. Thus, biallelic loss-of-function variants in CACNA2D1 underlie the severe neurodevelopmental disorder in these two patients. Our results demonstrate the critical importance and non-interchangeability of α2δ-1 and other α2δ proteins for normal human neuronal development.

Indexed as

Calcium Channels, N-TypeEpilepsyAge of OnsetAnimalsCalciumCalcium ChannelsCalcium Channels, L-TypeCell MembraneHumansMammalsNeuronsCACNA2D1 protein, humanCalciumCalcium ChannelsCalcium Channels, L-TypeCalcium Channels, N-Typebiallelic variantsCACNA2D1calcium channelepileptic encephalopathyloss-of-function

Identifiers

PMID35293990
PMCPMC9420018
OpenAlexW4214569149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.